MEI Pharma

Yahoo Finance • last year

11 Cheapest Stocks With Biggest Upside

In this piece, we will take a look at the 11 cheapest stocks with the biggest upside. If you want to skip our introduction to stock valuation and recent market news, then take a look at 5 Cheapest Stocks With Biggest Upside. Identifying t... Full story

Yahoo Finance • last year

Anson and Cable Car Send Letter to MEI Pharma Stockholders

File New Definitive Consent Materials to Remove Entire MEI Pharma Board for Cause and Add Advisory Proposal Requesting the Return of Capital to Stockholders Believe Company’s Latest Entrenchment Maneuvers Underscore Urgent Need for Board... Full story

Yahoo Finance • last year

Anson And Cable Car Send Letter to MEI Pharma Stockholders

File Definitive Consent Materials to Remove Entire MEI Pharma Board for Cause Believe Board Reconstitution is Urgently Required to Prevent the Further Destruction of Value and Ensure the Board is Acting in the Best Interest of Stockholder... Full story

Yahoo Finance • last year

MEI Pharma Postpones Special Meeting of Shareholders

SAN DIEGO, July 13, 2023--(BUSINESS WIRE)--MEI Pharma, Inc. (NASDAQ: MEIP) (the "Company") today announced that it has postponed its special meeting in connection with the proposed transaction with Infinity Pharmaceuticals, Inc. ("Infinity... Full story

Yahoo Finance • 2 years ago

Lacklustre Performance Is Driving MEI Pharma, Inc.'s (NASDAQ:MEIP) Low P/S

MEI Pharma, Inc.'s (NASDAQ:MEIP) price-to-sales (or "P/S") ratio of 0.5x might make it look like a strong buy right now compared to the Biotechs industry in the United States, where around half of the companies have P/S ratios above 11.8x... Full story

Yahoo Finance • 2 years ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SUMO, MEIP

NEW YORK, Feb. 26, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 2 years ago

Lifshitz Law PLLC Announces Investigations of VBLT, HRZN, INFI, and MEIP

NEW YORK, Feb. 25, 2023 (GLOBE NEWSWIRE) -- Vascular Biogenics Ltd. (NASDAQ: VBLT) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the merger of VBLT and Notable Labs, Inc. Follo... Full story

Yahoo Finance • 3 years ago

Bragar Eagel & Squire, P.C. Is Investigating Kohl’s, MEI Pharma, and TG Therapeutics and Encourages Investors to Contact the Firm

NEW YORK, June 13, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Kohl’s Corporation (NYSE: KSS), MEI Pharma, Inc. (NASDAQ: MEIP), and... Full story

Yahoo Finance • 3 years ago

MEI Pharma Investors: Company Investigated by the Portnoy Law Firm

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 18, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises MEI Pharma, Inc. (NASDAQ: MEIP) investors that the firm has initiated a... Full story

Yahoo Finance • 3 years ago

MEI Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, April 01, 2022--(BUSINESS WIRE)--MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced the grant of inducement stock options for an aggregate of 295,0... Full story

Yahoo Finance • 3 years ago

Revenue Downgrade: Here's What Analysts Forecast For MEI Pharma, Inc. (NASDAQ:MEIP)

Market forces rained on the parade of MEI Pharma, Inc. (NASDAQ:MEIP) shareholders today, when the analysts downgraded their forecasts for this year. Revenue estimates were cut sharply as analysts signalled a weaker outlook - perhaps a sign... Full story